Annals of the Rheumatic Diseases, ‎0003-4967

Journal

Publications

  1. 2021
  2. Accepted/In press

    EULAR points to consider for conducting clinical trials and observational studies in individuals at-risk of rheumatoid arthritis

    Karim Raza, , , , & , 24 Jul 2021, (Accepted/In press) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journalArticlepeer-review

  3. Published
  4. 2020
  5. Published
  6. Published
  7. Published
  8. Published
  9. Accepted/In press

    Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

    Lorraine Harper, Apr 2020, (Accepted/In press) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journalArticlepeer-review

  10. Published
  11. Accepted/In press
  12. Published

    Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care

    Raymond Oppong, , , , , , , Sue Jowett, , , , , , , & , Feb 2020, In: Annals of the Rheumatic Diseases. 79, 2, p. 276-284 9 p.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 4 5 6 7 8 ...17 Next